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Abstract
Background: The aim of this study was to estimate the impact of reducing the prevalence of obesity, smoking,
and physical inactivity, and introducing physical activity as an explicit intervention, on the burden of type 2
diabetes mellitus (T2DM), using Qatar as an example.
Methods: A population-level mathematical model was adapted and expanded. The model was stratified by sex,
age group, risk factor status, T2DM status, and intervention status, and parameterized by nationally representative
data. Modeled interventions were introduced in 2016, reached targeted level by 2031, and then maintained up to
2050. Diverse intervention scenarios were assessed and compared with a counter-factual no intervention baseline
scenario.
Results: T2DM prevalence increased from 16.7% in 2016 to 24.0% in 2050 in the baseline scenario. By 2050, through
halting the rise or reducing obesity prevalence by 10–50%, T2DM prevalence was reduced by 7.8–33.7%, incidence by
8.4–38.9%, and related deaths by 2.1–13.2%. For smoking, through halting the rise or reducing smoking prevalence by
10–50%, T2DM prevalence was reduced by 0.5–2.8%, incidence by 0.5–3.2%, and related deaths by 0.1–0.7%. For
physical inactivity, through halting the rise or reducing physical inactivity prevalence by 10–50%, T2DM prevalence was
reduced by 0.5–6.9%, incidence by 0.5–7.9%, and related deaths by 0.2–2.8%. Introduction of physical activity with
varying intensity at 25% coverage reduced T2DM prevalence by 3.3–9.2%, incidence by 4.2–11.5%, and related deaths
by 1.9–5.2%.
Conclusions: Major reductions in T2DM incidence could be accomplished by reducing obesity, while modest
reductions could be accomplished by reducing smoking and physical inactivity, or by introducing physical activity as
an intervention.
Keywords: Noncommunicable disease, type 2 diabetes mellitus, Obesity, Risk factors, Prevention, Mathematical
modeling, Middle East and North Africa
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Background
About 90% of individuals with diabetes mellitus have type
2 diabetes (T2DM), a largely preventable disease that is in-
fluenced by several modifiable risk factors such as obesity,
active smoking, physical inactivity, and unhealthy diet [1–
7]. In 2017, diabetes was estimated to cause 6.7 million
deaths, becoming the eighth leading cause of death world-
wide [8]. If no further action is taken, the epidemic of
diabetes is projected to increase from 425 million in 2017
to 629 million by 2045 [9].
Strategies to reduce and control the modifiable risk fac-
tors for T2DM have been previously demonstrated and
utilized [10–15], and could reduce the burden of T2DM
by averting new cases and preventing premature deaths.
The World Health Organization (WHO) recommends a
comprehensive global action plan for the prevention and
control of noncommunicable diseases (NCDs) including
diabetes [16]. The action plan provides a set of voluntary
global policy recommendations to attain national health
targets for 2025. These targets include a 25% relative re-
duction in premature mortality from NCDs between 2010
and 2025, halting the rise of both diabetes and obesity,
and reducing the prevalence of three behavioral risk fac-
tors for NCDs: tobacco use (by 30%), unhealthy diet (by
30%), and physical inactivity (by 10%) [16]. However, lim-
ited studies have quantitatively assessed the country-
specific effects of changes in these risk factors on T2DM
burden [17–19].
Diabetes prevalence in Qatar is twice the global preva-
lence [9]. In a recent modeling study, the prevalence of
T2DM among Qataris was projected to increase from
17% in 2012 to at least 24% by 2050 [20]. Obesity was
found to be the principal risk factor explaining nearly
two-thirds of T2DM incidence [20]. National T2DM
health expenditure was projected to account for up to
32% of Qatar’s total health expenditure by 2050 [20].
With the urgent need for effective public health strat-
egies to reduce the burden of T2DM in Qatar, the ob-
jective of this study was to evaluate the impact of several
generic intervention scenarios aimed at reducing the
prevalence of T2DM-related risk factors, on T2DM inci-
dent cases and related deaths. While this study is an
application for Qatar, as an illustrative example, the
methodology and approach developed here can be ap-
plied to other countries. Generally, the present study
demonstrates the impact of reducing T2DM-related risk
factors in countries with high T2DM prevalence, and
where specific guidelines to overcome T2DM challenges
are not yet in place.
Methods
We extended a recently developed T2DM age-structured
mathematical model by including intervention compart-
ments and their dynamics, representing individuals in the
intervention groups, to investigate the impact of different
generic intervention scenarios on T2DM epidemiology.
Details on the original model can be found in Awad et al.
[20]. Briefly, the model was a population-based determin-
istic compartmental model accounting for the epidemio-
logical dynamics of T2DM including key risk factors and
their overlap. The model was expressed by a set of differ-
ential equations stratifying the population according to
sex, age, risk factor (obesity, smoking, and physical inactiv-
ity) status, and T2DM status. Obesity was defined as BMI
> 30 kg/m2 across all age groups. The population was fur-
ther disaggregated by intervention status—every suscep-
tible state (no T2DM) in the model was categorized
according to the physical activity intervention status (see
Additional file 1: Figure S1). Further details on the model
structure and assumptions can be found in see Additional
file 1: Text S1 and Table S1.
The model was parameterized using epidemiological
and natural history data, listed in Additional file 1: Table
S2. Further discussion of parameter values is provided in
Awad et al. [20]. The model was fitted to sex- and age-
specific T2DM, obesity, smoking, and physical inactivity
prevalence data for Qataris using a nonlinear least-square
fitting method [21] and programmed in MATLAB 2015a
[22]. The model’s MATLAB codes can be obtained by
contacting the authors.
T2DM intervention scenarios targeting risk factors
The observation period for all intervention scenarios was
2016–2050. The starting year (2016) was chosen based
on the year Qatar launched the National Diabetes Strat-
egy [23]. For all modeled scenarios, we assumed that the
intervention was introduced in 2016 among Qataris aged
15–64 years and lasted for 15 years. This 15-year time
horizon was based on WHO’s recommendation for the
Global Action Plan for NCDs [16]. The prevalence of
each targeted risk factor achieved by 2031 was then
maintained between 2032 and 2050.
The modeled intervention scenarios targeted only the
susceptible (diabetes free) population, since the study
scope was to explore the impact of health interventions
on preventing T2DM incident cases and related deaths,
not on reducing further health complications associated
with T2DM.
The implications of the modeled intervention scenar-
ios were assessed through epidemiologic measures. For
each modeled scenario, the primary outcome of interest
was the predicted trend in T2DM prevalence among
adult Qataris aged 15–64 years between 2016 and 2050.
The predicted T2DM prevalence in the presence of the
intervention was then compared with the prevalence in a
counter-factual (baseline) scenario with no intervention,
as reported in Awad et al. [20]. In this baseline scenario,
the prediction for T2DM prevalence between 2016 and
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2050 was based on the assumption that the age-specific
prevalence of risk factors remained the same between
2016 and 2050 [20]. Accordingly, the trends in risk fac-
tors depended only on the demographic structure of the
population that is on the population distribution across
the different age groups. Of note that the average age of
the population is increasing steadily [20]—the Qatari
population is currently relatively young, but is expected
to age rapidly over time [20, 24].
We also estimated the number of T2DM cases averted
and reduction in T2DM-related deaths by comparing
the cumulative population-level T2DM incidence and
deaths in the presence of the intervention with the base-
line scenario.
The impact of the modeled scenarios on T2DM cases
and deaths was evaluated in two time horizons: an
intermediate-term (2016–2031) and a long-term time
horizon (2016–2050). The modeled intervention scenar-
ios are summarized in Table 1.
Impact of WHO’s Global Action Plan for NCDs
In this modeled intervention scenario, by implementing
the WHO’s Global Action Plan for NCDs [16], we inves-
tigated the impact of changing the prevalence of obesity,
smoking, and physical inactivity simultaneously. Based
on the 2016 prevalence for each risk factor, we halted
the prevalence of obesity and reduced (linearly) the
prevalence of smoking and physical inactivity by 30%
and 10%, respectively, between 2016 and 2031. Accord-
ingly, by 2031, the prevalence of obesity, smoking, and
physical inactivity reached 41.4%, 11.3%, and 41.4%,
respectively.
Impact of reducing the prevalence of T2DM-related risk
factors
In these modeled intervention scenarios, we focused on
three main risk factors for T2DM: obesity, smoking, and
physical inactivity. We generated three sets of scenarios
where the prevalence of each risk factor was separately re-
duced by various proportions between 2016 and 2031.
Based on the 2016 prevalence for each risk factor in the
Qatari population, we assumed a relative reduction in risk
factor prevalence of 10%, 20%, 30%, 40%, and 50% by 2031.
Accordingly, for the first set of scenarios, the preva-
lence of obesity was reduced from 41.4% in 2016 [20] to
37.3%, 33.1%, 29.0%, 24.8%, and 20.7% by 2031, respect-
ively. For the second set of scenarios, the prevalence of
smoking was reduced from 16.2% in 2016 [20] to 14.6%,
13.0%, 11.3%, 9.7%, and 8.1% by 2031, respectively. For
the third set of scenarios, the prevalence of physical in-
activity was reduced from 46.0% in 2016 [20] to 41.4%,
36.8%, 32.2%, 27.6%, and 23.0% by 2031, respectively.
We also investigated the impact of simultaneously re-
ducing the prevalence of obesity, smoking, and physical
inactivity by 50% by 2031. Accordingly, by 2031, the
prevalence of obesity, smoking, and physical inactivity
reached 20.7%, 8.1%, and 23.0%, respectively, and then
was maintained at these levels between 2032 and 2050.
In an additional analysis, given the prominent role of
obesity in driving T2DM incidence in Qatar [20], we
explored the impact of varying the duration of scale-up
for an intervention that reduces obesity prevalence by
40%. The different scale-up durations ranged between 5
to 20 years.
Impact of introducing different intensities of physical
activity as an intervention
In this modeled intervention scenario, physical activity
was introduced as an explicit intervention in the popula-
tion with varying levels of intensity—as opposed to
merely reducing the prevalence of physical inactivity, as
in the above-described scenarios. Physical activity as an
intervention was assumed to affect the population by re-
ducing the risk of developing T2DM among susceptible
(diabetes free) individuals (e.g., healthy, obese, smoker,
or physically inactive) in the intervention group. For in-
stance, individuals in the obese state that become phys-
ically active will have a lower risk of developing T2DM
in comparison with obese individuals that are not phys-
ically active. The relative risks of developing T2DM were
incorporated assuming independence of risk factors.
The impact of interventional physical activity on redu-
cing the risk of developing T2DM was assumed to
change with five different levels of physical activity. We
assumed that the relative risk for developing T2DM
(relative to the baseline of no intervention) was 0.61 for
vigorous activity, 0.66 for low-intensity activity, 0.68 for
moderate activity, 0.74 for leisure-time activity, and 0.85
for walking. These relative risks were based on a recent
systematic review and meta-analysis [25].
We assumed that interventional physical activity
coverage reached 25% in the population by 2031. The
25% coverage was based on evidence reporting an in-
crease in the proportion of the population that became
physically active in intervention strategies that created
and/or enhanced access to places for physical activity
combined with informational outreach activities [26].
In an additional analysis, we investigated the impact of
simultaneously reducing the prevalence of obesity,
smoking, and physical inactivity by 50% by 2031, com-
bined with 25% coverage of vigorous physical activity.
Results
Additional file 1: Figure S2 shows the model-projected
demographics of the Qatari population. The size of the
15–64-year-old population was estimated at 144,066;
201,499; and 221,627; in 2016, 2031, and 2050, respect-
ively. In the baseline scenario with no intervention, the
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total number of T2DM cases was estimated at 24,043;
37,104; and 53,207; in 2016, 2031, and 2050, respectively,
with the corresponding prevalence being 16.7%, 18.3%,
and 24.0%. Similarly for these years, the total number of
T2DM-related deaths was estimated at 206, 320, and
529, respectively, with the corresponding case fatality
rate being 8.6, 8.6, and 9.9 per 1000 persons per year.
Impact of WHO’s Global Action Plan for NCDs
The predicted impact on T2DM burden of reducing the
prevalence of T2DM risk factors to the levels recom-
mended by the WHO Global Action Plan for NCDs [16]
is described in Table 1 and Fig. 1. In the baseline scenario
with no intervention, T2DM prevalence increased from
16.7% in 2016 to 18.6% by 2031. In the intervention sce-
nario, T2DM prevalence reached 17.7% by 2031—4.7%
lower than in the baseline scenario. By 2050, T2DM
prevalence reached 24.0% in the baseline scenario and
21.0% in the intervention scenario—12.0% lower than in
the baseline scenario.
The model estimated that 2148 T2DM cases could be
averted between 2016 and 2031 in the intervention sce-
nario (i.e., 7.0% of new T2DM incident cases; Table 1
and Fig. 1b). Between 2016 and 2050, the number of
T2DM cases averted reached 9,147—13.2% of new
T2DM incident cases. Comparing the intervention sce-
nario to the baseline scenario, 28 T2DM-related deaths
could be prevented between 2016 and 2031 (i.e., 0.7% of
all T2DM-related deaths), while 383 T2DM-related
deaths could be prevented between 2016 and 2050—
3.2% of all T2DM-related deaths (Table 1 and Fig. 1c).
Impact of reducing the prevalence of each of the T2DM-
related risk factors
Figure 2 and Additional file 1: Figures S3 and S4 show
six modeled intervention scenarios for each of the
T2DM-related risk factors: obesity, smoking, and phys-
ical inactivity. These scenarios assessed the impact on
T2DM burden of reducing the prevalence of each risk
factor by 2031, and keeping it constant thereafter. The
scenarios ranged between halting the prevalence of the
risk factor at its 2016 level, to reducing it by 50% relative
to its 2016 level.
Reducing obesity prevalence
Across the six obesity reduction scenarios, by 2031,
obesity prevalence is reduced from 41.4% down to
20.7%. Accordingly, T2DM prevalence (absolute level)
ranged from 18.2% down to 15.1%; 2.0–18.8% lower than
in the baseline scenario (Table 1 and Fig. 2). The num-
ber of averted T2DM cases ranged from 958–8,688—
3.1–28.4% of new T2DM incident cases. In total, 15–151
T2DM-related deaths could be prevented—0.4–3.6% of
all T2DM-related deaths.
Similarly, by 2050, T2DM prevalence ranged from
22.0% down to 15.8%; 7.8–33.7% lower than in the base-
line scenario (Table 1 and Fig. 2). The number of
averted T2DM cases ranged from 5828–26,930—8.4–
38.9% of new T2DM incident cases. In total, 247–564
T2DM-related deaths could be prevented—2.1–13.2% of
all T2DM-related deaths.
In an additional analysis, reducing obesity prevalence
by 40% over 5, 10, 15, and 20 years, respectively, 7963;
6939; 6094; and 5642 T2DM incident cases were averted
by 2031, and 24,479; 23,473; 22,570; and 21,521 T2DM
cases by 2050 (see Additional file 1: Figure S5).
Reducing smoking prevalence
Across the six smoking reduction scenarios, by 2031,
smoking prevalence is reduced from 16.2% down to
8.1%. Accordingly, T2DM prevalence ranged between
18.6% down to 18.3%; 0.2–1.5% lower than in the base-
line scenario (Table 1 and see Additional file 1: Figure
S3). The number of T2DM cases averted ranged from
79–693—0.3–2.3% of new T2DM incident cases. In total,
1–9 T2DM-related deaths could be prevented—0.02–
0.2% of all T2DM-related deaths.
Similarly, by 2050, T2DM prevalence ranged between
23.8% down to 23.2%; 0.5–2.8% lower than in the base-
line scenario (Table 1 and see Additional file 1: Figure
S3). The number of T2DM cases averted ranged from
321–2184—0.5–3.2% of new T2DM incident cases. In
total, 11–86 T2DM-related deaths would be prevented—
0.1–0.7% of total T2DM-related deaths.
Reducing physical inactivity prevalence
Across the six physical inactivity reduction scenarios, by
2031, physical inactivity prevalence is reduced from
46.0% down to 23.0%. Accordingly, T2DM prevalence
ranged between 18.6% down to 17.9%; 0.2–3.7% lower
than in the baseline scenario (Table 1 and see Additional
file 1: Figure S4). The number of averted T2DM cases
ranged from 111–1744—0.4–5.7% of new T2DM inci-
dent cases. In total, 2–34 T2DM-related deaths could be
prevented—0.05–0.8% of all T2DM-related deaths.
Similarly, by 2050, T2DM prevalence ranged between
23.7% down to 22.2%; 0.5–6.9% lower than in the base-
line scenario (Table 1 and see Additional file 1: Figure
S4). The number of averted T2DM cases ranged from
350–5482—0.5–7.9% of new T2DM incident cases. In
total, 22–332 T2DM-related deaths could be pre-
vented—0.2–2.8% of all T2DM-related deaths.
Simultaneous reduction of risk factors
In the scenario of simultaneously reducing the preva-
lence of obesity, smoking, and physical inactivity by 50%,
T2DM prevalence reached 14.9% by 2031—20.0% lower
than in the baseline scenario (see Additional file 1:
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Fig. 1 Epidemiologic impact of reducing the prevalence of obesity, smoking, and physical inactivity according to the World Health Organization
Global Action Plan for Noncommunicable Diseases (NCDs). The figure shows the a projection of type 2 diabetes mellitus (T2DM) prevalence
among 15–64 years old Qataris, b number of T2DM cases averted, and c proportion of T2DM-related deaths averted. The red curve in panel a
shows the prediction of T2DM prevalence in the no intervention scenario (baseline scenario)
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Fig. 2 Epidemiologic impact of reducing the prevalence of obesity among Qataris 15–64 years of age. The figure shows the a projection of type
2 diabetes mellitus (T2DM) prevalence, b number of T2DM cases averted, and c proportion of T2DM-related deaths averted. The solid red curve
in panel a shows the prediction of T2DM prevalence in the no intervention scenario (baseline scenario)
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Figure S6A). By 2050, T2DM prevalence reached 15.0%
in the intervention scenario—37.0% lower than in the
baseline scenario.
Impact of introducing different intensities of physical
activity as an intervention
Figure 3 shows the five modeled scenarios that assessed
the impact on T2DM burden of increasing the coverage
of physical activity as an intervention. The intervention
coverage was increased steadily up to 25% by 2031 and
then kept constant at this level up to 2050. Though
coverage was set at 25%, the scenarios varied in the type
and intensity of physical activity being introduced as an
intervention, from walking up to vigorous activity.
Across these scenarios, by 2031, T2DM prevalence
ranged between 18.1% down to 17.1%; 2.9–7.9% lower
than in the baseline scenario (Table 1 and Fig. 3). The
number of averted T2DM cases ranged from 1375–
3689—4.5–12.0% of new T2DM incident cases. In total,
31–81 T2DM-related deaths could be prevented—0.7–
1.9% of all T2DM-related deaths.
Similarly, by 2050, T2DM prevalence ranged between
23.1% down to 21.7%; 3.3–9.2% lower than in the baseline
scenario (Table 1 and Fig. 3). The number of averted
T2DM cases ranged from 2892–7966—4.2–11.5% of new
T2DM incident cases. In total, 227–616 T2DM-related
deaths could be prevented—1.9–5.2% of all T2DM-related
deaths.
In the scenario simultaneously reducing the prevalence
of obesity, smoking, and physical inactivity by 50%, com-
bined with a 25% coverage of vigorous physical activity
in the population, T2DM prevalence reached 13.6% by
2031—27.1% lower than in the baseline scenario. By
2050, T2DM prevalence reached 13.2% in the interven-
tion scenario—44.5% lower than in the baseline scenario
(see Additional file 1: Figure S6B).
Discussion
Using an analytical approach, we investigated the impact
of several population-based interventions on reducing
the burden of T2DM in Qatar. By targeting and redu-
cing the prevalence of three key T2DM risk factors,
namely obesity, smoking, and physical inactivity, up to
46% of future T2DM cases and 14% of T2DM-related
deaths can be averted by 2050. While implementing the
WHO’s Global Action Plan for NCDs was predicted to
avert 13% of future T2DM cases and 3% of T2DM-
related deaths by 2050, this impact can only be seen as
modest in context of the large and growing T2DM epi-
demic in Qatar. These findings, therefore, highlight the
relevance of the present study in a context in which
Qatar has recently launched the National Diabetes Strat-
egy, urging the identification and development of T2DM
interventions [23].
The study results highlight that major reductions in
T2DM incidence can only be achieved by a marked re-
duction in obesity prevalence across teens and adults.
Reducing obesity prevalence by 50% can avert 39% of fu-
ture T2DM cases and 13% of T2DM-related deaths by
2050. Reducing the prevalence of smoking and physical
inactivity, each also by 50%, can avert only 3% and 8% of
T2DM cases, respectively, and 1% and 3% of T2DM-
related deaths. Introduction of physical activity as an
intervention, with varying levels of intensity and at a
coverage of 25%, can also only avert up to 12% of T2DM
cases and 5% of T2DM-related deaths by 2050. However,
the impact of simultaneously reducing obesity, smoking,
and physical inactivity levels combined with increasing
physical activity as an intervention can amplify the im-
pact on T2DM, and even reverse the growth in T2DM
prevalence (see Additional file 1: Figure S6).
These findings should not be surprising given that
obesity is the main driver of T2DM incidence in Qatar,
as demonstrated recently [20]. In 2016, 58% of T2DM
incidence was predicted to be attributed to obesity as a
risk factor, and by 2050, 66% of incidence was attributed
to obesity. While controlling the large and expanding
T2DM epidemic requires targeting the different T2DM’s
key risk factors, the results of the present analyses dem-
onstrate that the core focus should be on targeting obes-
ity. It will be virtually impossible to make a major dent
on this epidemic without an aggressive intervention
against this risk factor.
Despite the potential impact of targeting these key risk
factors, the results also highlight the challenges in halt-
ing or reversing the expanding T2DM epidemic in
Qatar. Even assuming constant age-specific prevalence
for the risk factors between 2016 and 2050, T2DM
prevalence was projected to increase by 43%, driven by
the fairly rapid aging of the Qatari population [20]. In all
intervention scenarios, apart from targeting obesity,
T2DM prevalence was projected to increase despite the
intervention’s impact in reducing T2DM incidence. Even
when targeting obesity, T2DM prevalence in 2050 will
be higher than that in 2016 unless obesity can be re-
duced by over 40% by 2031, which seems unlikely (Table
1 and Fig. 2). Faster scale-up of interventions may help
halt or reverse the rising T2DM prevalence (noting the
example presented for obesity in see Additional file 1:
Figure S5), but there is uncertainty over whether such
rapid scale-up of reductions in risk factors are feasible.
In reviewing the literature, there does not appear yet to
be relevant examples of wide scale population-based in-
terventions that have demonstrated substantial impact.
It is also evident that efforts to tackle obesity cannot be
limited to community awareness programs designed to
improve knowledge and encourage personal responsibil-
ity, as it has been the case in Qatar in recent years.
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While halting the growing T2DM prevalence is difficult
to accomplish, public health response should be focused
on reducing the onset of new T2DM cases, in other words
reducing incidence. The results presented here demon-
strate that the reductions in risk factors, particularly obes-
ity, can lead to large reductions in incidence. Despite the
clear difficulties, existing evidence suggests that some
reductions may be feasible [10–15]. As demonstrated by
the Finnish, Chinese, and American diabetes prevention
studies, behavioral lifestyle changes were feasible and led
to weight loss resulting in as much as a 40% reduction in
T2DM incidence [10–12]. Further to these approaches,
fiscal and legislative strategies, such as taxation, marketing
restrictions, improved food labeling, and reductions in
Fig. 3 Epidemiologic impact of increasing the coverage of various levels of physical activity as an intervention among Qataris 15–64 years of age.
The intervention coverage was increased steadily up to 25% by 2031, and then kept constant at this level up to 2050. The figure shows the a
projection of type 2 diabetes mellitus (T2DM) prevalence, b number of T2DM cases averted, and c proportion of T2DM-related deaths averted.
The solid red curve in panel a shows the baseline prediction of T2DM prevalence of the no intervention scenario (baseline scenario)
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portion sizes, could be promising in reducing these risk
factors [27, 28].
The French EPODE program (Ensemble, Prevenons
l’Obésité des Enfants) is an example of a community-
based multi-faceted intervention strategy that turned out
to be effective with 9% reduction between 2005 and 2009
in overweight and obesity among school children [29].
Mexico’s 10% tax on sugar-sweetened beverages is another
example of a successful intervention where nearly 190,000
new T2DM cases could be prevented over the next 10
years [28]. The NOURISHING framework is yet a com-
prehensive policy package (that is applicable globally) to
promote healthier eating and prevent obesity [30, 31]. It
recognizes that policy actions are needed within the food
environment, food system, and behavior change commu-
nication to reduce obesity and intake of unhealthy diets.
Though the actual impact of the latter strategy (or similar
strategies) is still not quantified, this type of strategies is
having increasingly more global attention [32].
There is undoubtedly a need to multiply the current ef-
forts on education and counseling on behavioral change
to control obesity and T2DM in Qatar. However, govern-
mental support structures should widen their reach to
target the overall food environment. In particular, the
abundance and ease of access to calorie-dense unhealthy
food, subjecting the consumer to market control, have
had their share in fueling the development of unhealthy
dietary habits. Controlling the unhealthy environmental
triggers can only be achieved by robust policies such as
food taxation and restrictive legislation imposed on food
markets to gradually shape a healthier food culture.
Considerations and limitations may have affected our
results. Our results may depend on the type of mathem-
atical model used and can be affected by the availability
of representative epidemiological and demographic input
data. Since we explored hypothetical scenarios, we did
not conduct uncertainty analyses. We assumed specific
parameter values and did not explore variability in these
parameters. Having said so, the uncertainty interval of
the impact of the interventions is likely to be narrow, in
view of the earlier uncertainty analysis, we conducted for
the projections of T2DM in Qatar [20]. In most analyses,
we assumed a fixed rate of reduction in risk factors, but
the rate of reduction may vary from 1 year to another in
actual implementation. However, we examined the im-
pact of using variable scale-up rates for the case of obes-
ity reduction, and the results affirmed our findings (see
Additional file 1: Figure S5).
While we parameterized our model using relevant and
current epidemiological input data, the availability of re-
peated rounds of nationally representative population-
based surveys may have improved the model’s ability to
make long-term predictions. Only one round of nation-
ally representative survey, the 2012 STEPwise survey
[33] was available to use as input for our model. The
survey included 2496 Qataris aged 18–64 years old and
collected data on DM prevalence using fasting capillary
blood glucose testing, while the prevalence of smoking
and physical inactivity was estimated based on self-
report [33]. The definition of obesity in the survey and
in our study was uniform across all age groups, but there
is evidence suggesting that the cutoff for obesity might
vary across age groups and ethnicity [34].
We focused strictly on reducing obesity in the popula-
tion, but this may underestimate the impact on T2DM
incidence of small reductions in BMI—reductions that
do not cross the obesity threshold, but still can reduce
T2DM incidence [10–12]. In the analyses examining the
impact of physical activity as an intervention, we only
factored the direct effect of physical activity on T2DM
incidence, which also may underestimate the impact, if
this intervention will also impact T2DM incidence indir-
ectly by reducing obesity. However, most studies have
identified only small effects of physical activity on weight
change [35]. Our study was focused on T2DM, but the
reduction in the risk factors would also lower the inci-
dence of other serious morbidities. While the reductions
in smoking and physical inactivity affected T2DM inci-
dence rather modestly, such reductions may have had a
large impact on reducing simultaneously other NCD
morbidities, such as cancer and cardiovascular diseases.
Conclusions
In conclusion, halting or reversing the expanding T2DM
epidemic in Qatar, as elsewhere, is very challenging. How-
ever, major reductions in T2DM incidence could be ac-
complished by targeting the key risk factors driving
T2DM incidence, in particular obesity, the leading driver
of incidence. Nearly 40% of T2DM incidence can be pre-
vented in 2050 by reducing obesity prevalence by 50%.
Even modest and more realistic reductions in obesity
would have a sizeable impact on T2DM incidence. These
findings affirm the relevance of the concept of population-
level risk factor intervention-for-prevention, as a critical
and indispensable approach to addressing the rising dis-
ease burden of T2DM in this nation.
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